Broad humoral and cellular immunity elicited by one-dose mRNA vaccination 18 months after SARS-CoV-2 infection.
Chang Kyung KangHyun Mu ShinPyoeng Gyun ChoeJiyoung ParkJisu HongJung Seon SeoYung Hie LeeEuijin ChangNam Joong KimMinji KimYong-Woo KimHang-Rae KimChang-Han LeeJun-Young SeoPyoeng Gyun ChoeMyoung-Don OhPublished in: BMC medicine (2022)
One dose of mRNA vaccine should be considered sufficient to elicit a broad immune response even around 18 months after a COVID-19 diagnosis.